Back to Search
Start Over
DuoResp ® Spiromax ® adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT).
- Source :
-
The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2020 Oct; Vol. 57 (10), pp. 1110-1118. Date of Electronic Publication: 2019 Jul 11. - Publication Year :
- 2020
-
Abstract
- Objective: Adherence and inhaler technique are often suboptimal in asthma and chronic obstructive pulmonary disease (COPD). New inhalers have been developed to improve these determinants of treatment effectiveness. We assessed treatment adherence, satisfaction, and ease of use of DuoResp <superscript>®</superscript> Spiromax <superscript>®</superscript> among SPRINT study participants. Methods: The Phase IV SPRINT study was conducted in 10 European countries. Asthma and COPD patients were receiving a fixed-dose combination of inhaled corticosteroid (ICS) and long-acting β <subscript>2</subscript> -agonist (LABA), delivered via various inhalers including DuoResp Spiromax. DuoResp Spiromax users self-assessed adherence using the 8-item Morisky Medication Adherence Scale (MMAS-8 <superscript>®</superscript> ), and ease of use and satisfaction using 10-point scales, during a single physician's office visit. Results: Of 1661 (asthma: n = 1101; COPD: n = 560) SPRINT study participants, 342 (asthma: n = 235; COPD: n = 107) received DuoResp Spiromax prior to inclusion. Overall, 72.5% of DuoResp Spiromax users reported medium or high adherence (MMAS-8 score ≥6). Mean (standard deviation [SD]) satisfaction score for DuoResp Spiromax was 8.9 (1.6). Almost all (98.8%) DuoResp Spiromax users were at least satisfied with their inhaler; 85.4% were very satisfied. Mean (SD) ease of use score for DuoResp Spiromax was 9.1 (1.3). Conclusions: Asthma and COPD patients using DuoResp Spiromax reported moderate-to-high medication adherence, were very satisfied with their inhaler and found it easy to use.
- Subjects :
- Administration, Inhalation
Adult
Aged
Bronchodilator Agents administration & dosage
Budesonide, Formoterol Fumarate Drug Combination administration & dosage
Drug Combinations
Dry Powder Inhalers
Europe
Female
Humans
Middle Aged
Severity of Illness Index
Asthma drug therapy
Bronchodilator Agents therapeutic use
Budesonide, Formoterol Fumarate Drug Combination therapeutic use
Medication Adherence statistics & numerical data
Patient Satisfaction
Pulmonary Disease, Chronic Obstructive drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1532-4303
- Volume :
- 57
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- The Journal of asthma : official journal of the Association for the Care of Asthma
- Publication Type :
- Academic Journal
- Accession number :
- 31293211
- Full Text :
- https://doi.org/10.1080/02770903.2019.1634097